Expression of CDK5/p35 in resected patients with non-small cell lung cancer: Relation to prognosis

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 673-678

  Liu, Jun Li ^a   Wang, Xiao Yan ^a   Huang, Bang Xing ^a   Zhu, Fang ^a   Zhang, Rui Guang ^a   Wu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CDK5 p35; Non small cell lung cancer; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN P35;

ADULT; AGED; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TUMOR CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 5; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80052476422     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9510-7     Document Type: Review

References (22)

1. M Pirozynski 2006 100 years of lung cancer Respir Med 100 2073 2084 17056245 10.1016/j.rmed.2006.09.002
2. MQ Baggstrom TE Stinchcombe DB Fried C Poole TA Hensing MA Socinski 2007 Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis J Thorac Oncol 2 845 853 17805063 10.1097/JTO.0b013e31814617a2
3. Non-small Cell Lung Cancer Collaborative Group 1995 Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 899 909
4. LH Tsai 2004 A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease Curr Opin Neurobiol 14 390 394 15194121 10.1016/j.conb.2004.05.002
5. C Gao S Negash HS Wang D Ledee H Guo P Russell, et al. 2001 Cdk5 mediates changes in morphology and promotes apoptosis of astrocytoma cells in response to heat shock J Cell Sci 114 1145 1153 11228158 1:CAS:528:DC%2BD3MXivVKitbw%3D
6. T Sandal C Stapnes H Kleivdal L Hedin SO Doskeland 2002 A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMP-induced apoptosis in rat leukemia cells J Biol Chem 277 20783 20793 11909854 10.1074/jbc.M112248200 1:CAS:528:DC%2BD38XkslWnsro%3D
7. CJ Strock JI Park EK Nakakura GS Bova JT Isaacs DW Ball, et al. 2006 Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells Cancer Res 66 7509 7515 16885348 10.1158/0008-5472.CAN-05-3048 1:CAS:528:DC%2BD28XnsFyrtbg%3D
8. S Goodyear MC Sharma 2007 Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5 Exp Mol Pathol 82 25 32 17081516 10.1016/j.yexmp.2006.09.002 1:CAS:528:DC%2BD2sXisVCksg%3D%3D
9. H Lin MC Chen CY Chiu YM Song SY Lin 2007 Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells J Biol Chem 282 2776 2784 17145757 10.1074/jbc.M607234200 1:CAS:528:DC%2BD2sXptFCnsw%3D%3D
10. E Sahai 2005 Mechanisms of cancer cell invasion Curr Opin Genet Dev 15 87 96 15661538 10.1016/j.gde.2004.12.002 1:CAS:528:DC%2BD2MXmvFertw%3D%3D
11. AJ Ridley 2004 Rho proteins and cancer Breast Cancer Res Treat 84 13 19 14999150 10.1023/B:BREA.0000018423.47497.c6 1:CAS:528:DC%2BD2cXhslGjtbc%3D
12. SL Bielas JG Gleeson 2004 Cytoskeletal-associated proteins in the migration of cortical neurons J Neurobiol 58 149 159 14598377 10.1002/neu.10280 1:CAS:528:DC%2BD2cXlvVelsg%3D%3D
13. AJ Ridley MA Schwartz K Burridge RA Firtel MH Ginsberg G Borisy, et al. 2003 Cell migration: integrating signals from front to back Science 302 1704 1709 14657486 10.1126/science.1092053 1:CAS:528:DC%2BD3sXpsVWns7o%3D
14. K Burridge K Wennerberg 2004 Rho and Rac take center stage Cell 116 167 179 14744429 10.1016/S0092-8674(04)00003-0 1:CAS:528:DC%2BD2cXhtValsrs%3D
15. W Wang S Goswami E Sahai JB Wyckoff JE Segall JS Condeelis 2005 Tumor cells caught in the act of invading: their strategy for enhanced cell motility Trends Cell Biol 15 138 145 15752977 10.1016/j.tcb.2005.01.003 1:CAS:528:DC%2BD2MXitVeitrc%3D
16. W Wang S Goswami K Lapidus AL Wells JB Wyckoff E Sahai, et al. 2004 Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors Cancer Res 64 8585 8594 15574765 10.1158/0008-5472.CAN-04-1136 1:CAS:528:DC%2BD2cXhtVCjs73N
17. J Lew QQ Huang Z Qi RJ Winkfein R Aebersold T Hunt, et al. 1994 A brain-specific activator of cyclin-dependent kinase 5 Nature 371 423 426 8090222 10.1038/371423a0 1:CAS:528:DyaK2MXhtVGhsrc%3D
18. LH Tsai I Delalle VS Caviness Jr T Chae E Harlow 1994 p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 Nature 371 419 423 8090221 10.1038/371419a0 1:CAS:528:DyaK2cXmslGiu7w%3D
19. WW Lockwood R Chari BP Coe L Girard C Macaulay S Lam, et al. 2008 DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers Oncogene 27 4615 4624 18391978 10.1038/onc.2008.98 1:CAS:528: DC%2BD1cXptFSku7c%3D
20. HS Choi Y Lee KH Park JS Sung JE Lee ES Shin, et al. 2009 Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population J Hum Genet 54 298 303 19343042 10.1038/jhg.2009.29 1:CAS:528:DC%2BD1MXnsF2qsrc%3D
21. B Schutte L Nieland M van Engeland ME Henfling L Meijer FC Ramaekers 1997 The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics Exp Cell Res 236 4 15 9344580 10.1006/excr.1997.3700 1:CAS:528:DyaK2sXms1GjtLo%3D
22. MD Garrett A Fattaey 1999 CDK inhibition and cancer therapy Curr Opin Genet Dev 9 104 111 10072351 10.1016/S0959-437X(99)80015-X 1:CAS:528: DyaK1MXhsFSntb4%3D